Clinical Trials Directory

Trials / Conditions / Acute Lymphoblastic Leukemia, Adult B-Cell

Acute Lymphoblastic Leukemia, Adult B-Cell

7 registered clinical trials studyying Acute Lymphoblastic Leukemia, Adult B-Cell3 currently recruiting.

StatusTrialSponsorPhase
RecruitingFourth-gen CAR T Cells Targeting CD19/CD22 for Highly Resistant B-cell Lymphoma/Leukemia (PMBCL/CNS-BCL).
NCT06213636
Essen BiotechPhase 1 / Phase 2
RecruitingPrevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transpla
NCT06462365
Tr1X, Inc.Phase 1
UnknownImpact of Cross-training on Induction Treatment Response in Acute Lymphoblastic Leukemia Adults
NCT05059847
Hospital General de MexicoN/A
TerminatedThe clonoSEQ® Watch Registry
NCT04545333
Adaptive Biotechnologies
Active Not RecruitingBlinatumomab in High-risk B-cell Precursor Acute Lymphoblastic Leukemia
NCT03709719
Assistance Publique - Hôpitaux de ParisPhase 2
RecruitingCD19 CAR-T Consolidation Therapy for Acute Lymphoblastic Leukemia
NCT03984968
The First Affiliated Hospital of Soochow UniversityPhase 1 / Phase 2
CompletedCD19 CAR T Cells in Patients With Resistant or Refractory CD19+ Acute Lymphoblastic Leukemia
NCT02975687
Institute of Hematology & Blood Diseases Hospital, ChinaPhase 1